Press Release – 01/11/22
SurePulse Medical Ltd, along with partners The University of Nottingham and Tioga Ltd, is delighted to announce that the consortium has won an Innovate UK competitive grant award of £1.4m. The project is to develop and prepare regulatory submissions for a new vital-signs monitoring system.
James Carpenter, CEO of SurePulse said: “The need for innovative medical devices is more important than ever as our healthcare systems experience unprecedented pressure. Neonatal Care is now very high on Governmental and Payers’ agendas – many gains have been made but there still remain great opportunities to reduce deaths and brain injuries in newborn babies. We are very proud to have won this grant along with our partners and look forward to seeing the impact of this award in making a real difference to the care of newborn babies and their families.”
Please direct any enquiries to info@surepulsemedical.com or telephone on 0333 577 1133
About SurePulse
SurePulse Medical Ltd is committed to developing innovative and baby-centric solutions to unmet clinical needs, improving the life chances of premature and sick babies.
SurePulse Medical Ltd, based at Medicity in Nottingham, was established in 2014 as a joint venture between the University of Nottingham and Tioga Ltd, thereby combining the academic strength of the University with the expertise of one of the UK’s premier contract manufacturers. Its first product, the SurePulse VS, is CE and FDA 510(k) approved wireless heart rate monitor designed to provide early, accurate and continuous information to guide newborn care at birth.
For more information:
Website: www.surepulsemedical.com
Email: info@surepulsemedical.com
Tel: 0333 577 1133